CIRCADIAN FLUCTUATIONS OF TISSUE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 ANTIGENS IN VASOSPASTIC ANGINA

被引:38
|
作者
SAKATA, K
HOSHINO, T
YOSHIDA, H
ONO, N
OHTANI, S
YOKOYAMA, S
MORI, N
KABURAGI, T
KURATA, C
URANO, T
TAKADA, Y
TAKADA, A
机构
[1] HAMAMATSU UNIV SCH MED, DEPT INTERNAL MED 3, HAMAMATSU, SHIZUOKA 43131, JAPAN
[2] HAMAMATSU UNIV SCH MED, DEPT PHYSIOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
关键词
D O I
10.1016/0002-8703(92)90964-W
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To elucidate the circadian variation of fibrinolytic components in vasospastic angina, plasma levels of tissue plasminogen activator antigen (t-PA), free plasminogen activator inhibitor antigen (free PAI-1), t-PA/PAI-1 complex, and total PAI-1 were measured in venous plasma samples. Samples were taken every 6 hours (6:00 AM, noon, 6:00 PM, and midnight) for 24 hours in 14 patients with vasospastic angina, in 9 patients with exertional angina, and in 19 normal subjects. Twenty-four-hour Holter monitoring (Holter monitor, Del Mar Avionics, Irvine, Calif.) was also carried out in all subjects. All of the fibrinolytic components showed circadian variation, with a peak level at 6:00 AM in every study group except for the t-PA/PAI-1 complex in the group of patients with exertional angina. The values for all of the fibrinolytic components at each sampling time were higher in patients with coronary artery disease than in normal subjects. In particular, the mean value of free PAI-1 at 6:00 AM in patients with vasospastic angina was significantly higher than that in normal subjects and that in patients with exertional angina. This value of free PAI-1 in patients with vasospastic angina was closely associated with the duration of ischemic attacks. These results suggested that the circadian fluctuation of fibrinolytic components may be an important factor that leads to coronary thrombosis at the time of coronary spasm, especially in the early morning.
引用
收藏
页码:854 / 860
页数:7
相关论文
共 50 条
  • [21] TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS
    AUWERX, J
    BOUILLON, R
    COLLEN, D
    GEBOERS, J
    ARTERIOSCLEROSIS, 1988, 8 (01): : 68 - 72
  • [22] KINETIC-ANALYSIS OF THE INTERACTIONS BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND BOTH UROKINASE AND TISSUE PLASMINOGEN-ACTIVATOR
    HEKMAN, CM
    LOSKUTOFF, DJ
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 262 (01) : 199 - 210
  • [23] INTERACTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 ON THE SURFACE OF ENDOTHELIAL-CELLS
    SAKATA, Y
    OKADA, M
    NORO, A
    MATSUDA, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (04) : 1960 - 1969
  • [24] KINETIC-ANALYSIS OF THE INTERACTION BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    MASSON, C
    ANGLESCANO, E
    BIOCHEMICAL JOURNAL, 1988, 256 (01) : 237 - 244
  • [25] TISSUE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS IN PATIENTS WITH NON-DISSOLVING PULMONARY THROMBOEMBOLISM
    MOSER, KM
    MITCHELL, MA
    MARSH, JJ
    BINDER, BR
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 96 - 96
  • [26] PLASMA CHANGES OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 DURING CORONARY THROMBOLYSIS WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    OTTANI, F
    GALVANI, M
    NICOLINI, FA
    RONCHI, A
    FERRINI, D
    RUSTICALI, F
    CIRCULATION, 1993, 88 (04) : 320 - 320
  • [27] TGF-BETA INCREASES BOTH UROKINASE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    IWASA, M
    HASHIMOTO, K
    MATSUMOTO, K
    HIGASHIYAMA, M
    HASHIRO, M
    UEDA, K
    KIM, K
    NISHIDA, Y
    TAGO, H
    YOSHIKAWA, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 451 - 451
  • [28] TGF-BETA INCREASES BOTH UROKINASE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    IWASA, M
    HASHIMOTO, K
    MATSUMOTO, K
    HIGASHIYAMA, M
    HASHIRO, M
    UEDA, K
    KIM, K
    NISHIDA, Y
    TAGO, H
    YOSHIKAWA, K
    CLINICAL RESEARCH, 1989, 37 (02): : A635 - A635
  • [29] EFFECT OF PROPRANOLOL (LONG-ACTING) ON THE CIRCADIAN FLUCTUATION OF TISSUE-PLASMINOGEN ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1
    ANDREOTTI, F
    KLUFT, C
    DAVIES, GJ
    HUISMAN, LGM
    DEBART, ACW
    MASERI, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (13): : 1295 - 1299
  • [30] ANTIGENS OF TISSUE-PLASMINOGEN ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 - CORRELATES IN NONSMOKING JAPANESE AND CAUCASIAN MEN AND WOMEN
    ISO, H
    FOLSOM, AR
    KOIKE, KA
    SATO, S
    WU, KK
    SHIMAMOTO, T
    IIDA, M
    KOMACHI, Y
    THROMBOSIS AND HAEMOSTASIS, 1993, 70 (03) : 475 - 480